Ifosfamide bladder toxicity cyclophosphamide. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Urinary Bladder Urothelium Bone Marrow Kidney

Diseases48

Urinary Bladder Diseases Urinary Bladder Neoplasms Sarcoma Cystitis Urinary Bladder, Overactive Soft Tissue Neoplasms Leukopenia Urinary Bladder, Neurogenic Carcinoma, Transitional Cell Lymphoma, Non-Hodgkin Urinary Bladder Neck Obstruction Sarcoma, Ewing Neutropenia Germinoma Breast Neoplasms Urinary Bladder Calculi Bone Neoplasms Lung Neoplasms Carcinoma, Small Cell Neoplasms Thrombocytopenia Hematologic Diseases Testicular Neoplasms Neoplasm Recurrence, Local Osteosarcoma Neuroectodermal Tumors, Primitive Recurrence Alopecia Neoplasms, Germ Cell and Embryonal Rhabdomyosarcoma Hematuria Bladder Exstrophy Fanconi Syndrome Vomiting Neoplasm Metastasis Bone Marrow Diseases Nausea Agranulocytosis Hodgkin Disease Carcinosarcoma Wegener Granulomatosis Lupus Nephritis Lymphoma, Large B-Cell, Diffuse Ovarian Neoplasms Retroperitoneal Neoplasms Disease Progression Lymphoma Mediastinal Neoplasms

Chemicals and Drugs58

Ifosfamide Cyclophosphamide Mesna Antineoplastic Agents, Alkylating Doxorubicin Etoposide Vincristine Phosphoramide Mustards Cisplatin Methotrexate Carboplatin Epirubicin Prednisone Granulocyte Colony-Stimulating Factor Immunosuppressive Agents Paclitaxel Antineoplastic Agents Fluorouracil Thiotepa Bleomycin Busulfan Vinblastine Prednisolone Antibodies, Monoclonal, Murine-Derived Carbocysteine Carmustine Taxoids Prodrugs Melphalan Vidarabine Protective Agents Antibiotics, Antineoplastic Cytochrome P-450 CYP2B1 Cytarabine Mitomycin Mitoxantrone Methylprednisolone Antineoplastic Agents, Phytogenic Dexamethasone Acetaldehyde Bromisovalum Acrolein Azathioprine Mercaptoethanol Dacarbazine Deoxycytidine Vindesine Chlorambucil Antidotes Dactinomycin Alkylating Agents Mitomycins Antibodies, Monoclonal Procarbazine Anthracyclines Antimetabolites, Antineoplastic Oxidoreductases, N-Demethylating Recombinant Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment45

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Combined Modality Therapy Treatment Outcome Disease-Free Survival Remission Induction Survival Analysis Salvage Therapy Toxicity Tests Infusions, Intravenous Survival Rate Transplantation, Autologous Pulse Therapy, Drug Chemotherapy, Adjuvant Drug Evaluation Neoplasm Staging Hematopoietic Stem Cell Transplantation Bone Marrow Transplantation Follow-Up Studies Prognosis Hematopoietic Stem Cell Mobilization Drug Therapy, Combination Administration, Oral Toxicity Tests, Acute Prospective Studies Neoadjuvant Therapy Feasibility Studies Cystoscopy Whole-Body Irradiation Administration, Intravesical Administration, Metronomic Pilot Projects Transplantation Conditioning Maximum Tolerated Dose Leukocyte Count Retrospective Studies Injections, Intravenous Immunosuppression Lethal Dose 50 Neoplasm Transplantation Cystectomy Leukapheresis Area Under Curve Transplantation, Homologous Radiotherapy, Adjuvant

Phenomena and Processes10

Dose-Response Relationship, Drug Time Factors Urination Biotransformation Maximum Tolerated Dose Leukocyte Count Lethal Dose 50 Area Under Curve Urodynamics Drug Resistance, Neoplasm

Information Science1

Named Groups1

Pharmacists' Aides

Health Care11

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Prospective Studies Feasibility Studies Pharmacists' Aides Pilot Projects Retrospective Studies Area Under Curve

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Named Groups Health Care

Ifosfamide Urinary Bladder Diseases Urinary Bladder Cyclophosphamide Mesna Urinary Bladder Neoplasms Antineoplastic Agents, Alkylating Antineoplastic Combined Chemotherapy Protocols Doxorubicin Etoposide Vincristine Phosphoramide Mustards Drug Administration Schedule Cisplatin Sarcoma Combined Modality Therapy Treatment Outcome Methotrexate Carboplatin Epirubicin Dose-Response Relationship, Drug Prednisone Cystitis Granulocyte Colony-Stimulating Factor Disease-Free Survival Urinary Bladder, Overactive Remission Induction Soft Tissue Neoplasms Survival Analysis Leukopenia Salvage Therapy Toxicity Tests Infusions, Intravenous Survival Rate Immunosuppressive Agents Urinary Bladder, Neurogenic Carcinoma, Transitional Cell Paclitaxel Transplantation, Autologous Antineoplastic Agents Lymphoma, Non-Hodgkin Pulse Therapy, Drug Urinary Bladder Neck Obstruction Sarcoma, Ewing Neutropenia Germinoma Breast Neoplasms Urinary Bladder Calculi Bone Neoplasms Chemotherapy, Adjuvant Lung Neoplasms Fluorouracil Drug Evaluation Time Factors Thiotepa Neoplasm Staging Bleomycin Hematopoietic Stem Cell Transplantation Busulfan Vinblastine Carcinoma, Small Cell Neoplasms Urothelium Thrombocytopenia Bone Marrow Transplantation Prednisolone Hematologic Diseases Antibodies, Monoclonal, Murine-Derived Follow-Up Studies Testicular Neoplasms Prognosis Carbocysteine Carmustine Taxoids Prodrugs Melphalan Hematopoietic Stem Cell Mobilization Neoplasm Recurrence, Local Osteosarcoma Vidarabine Neuroectodermal Tumors, Primitive Recurrence Drug Therapy, Combination Administration, Oral Alopecia Neoplasms, Germ Cell and Embryonal Toxicity Tests, Acute Urination Protective Agents Rhabdomyosarcoma Antibiotics, Antineoplastic Cytochrome P-450 CYP2B1 Cytarabine Hematuria Prospective Studies Biotransformation Bladder Exstrophy Mitomycin Mitoxantrone Neoadjuvant Therapy

No FAQ available that match "ifosfamide bladder toxicity cyclophosphamide"